Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
Study on the Effects of Atuliflapon in Adults with Moderate to Severe Uncontrolled Asthma
BulgariaStudy on the Effectiveness and Safety of Barzolvolimab in Adults with Active Eosinophilic Esophagitis
GermanyStudy of anifrolumab effectiveness compared to placebo in adults aged 18-70 with systemic sclerosis
AustriaSafety Study of Efgartigimod in Adults with Primary Sjögren's Syndrome
BelgiumStudy on Tezepelumab for Reducing Steroid Use in Adults with Steroid-Dependent Asthma
CzechiaStudy on Long-Term Safety and Efficacy of Deucravacitinib for Patients with Systemic Lupus Erythematosus
HungaryStudy Comparing CT-P53 and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis
BulgariaStudy on the Effectiveness and Safety of Tanimilast for Patients with Uncontrolled Asthma on Inhaled Corticosteroid and Long-Acting Beta2-Agonist Therapy
BulgariaStudy on the Safety of CHF5993 Inhaler with HFA-152a vs. HFA-134a in Patients with Moderate to Severe Asthma
BulgariaStudy on the Effectiveness and Safety of Methotrexate Compared to Placebo for Adults with Moderate to Severe Atopic Dermatitis
CzechiaStudy of GLPG3667 for Adults with Active Systemic Lupus Erythematosus
BulgariaStudy on Deucravacitinib and Apremilast for Patients with Active Psoriatic Arthritis New to Biologic Treatments or Previously on TNFα Inhibitors
BelgiumThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
